Company · CIK 0001869105 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
BridgeBio Oncology Therapeutics, Inc. · BBOT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 AFForm 4 → | Sep 14, 4:24 pm EDT | Marc CoboPrincipal Accounting Officer | 9,241 | $5.52 | $1,121 | 14,141 | — | |
| Jul 1, 2026 FForm 4 → | Jul 6, 6:00 pm EDT | Marc CoboPrincipal Accounting Officer | 125 | $7.80 | $975 | 5,306 | — | |
| Jul 1, 2026 FForm 4 → | Jul 6, 6:00 pm EDT | Idan ElmelechCOO & Principal Financial Ofcr | 343 | $7.80 | $2,675 | 14,495 | — | |
| Jul 1, 2026 FForm 4 → | Jul 6, 6:00 pm EDT | Yong BenChief Med & Dev Officer | 1,047 | $7.80 | $8,167 | 44,576 | — | |
| Jul 1, 2026 FForm 4 → | Jul 6, 6:00 pm EDT | Pedro BeltranPresident and CEO, Director | 1,047 | $7.80 | $8,167 | 44,576 | — | |
| Jul 1, 2026 JForm 4 → | Jul 6, 4:34 pm EDT | Bihua ChenDirector, 10% Owner | 9,056,372 | — | — | 6,083,221 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 AForm 4 → | Sep 14, 4:24 pm EDT | Marc CoboPrincipal Accounting Officer | 43,700 | — | — | 43,700 | — |